These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 6328639
1. Alterations in T-lymphocyte subsets among Danish haemophiliacs: relation to source of factor VIII preparations and high dose factor VIII treatment. Gerstoft J, Bentsen K, Scheibel E, Dalsgård-Nielsen J, Gormsen J, Dickmeiss E. Scand J Haematol; 1984 May; 32(5):544-51. PubMed ID: 6328639 [Abstract] [Full Text] [Related]
2. Antibodies against HTLV-III in Danish haemophiliacs: relation to source of factor VIII used in treatment and immunological parameters. Lindhardt BO, Gerstoft J, Ulrich K, Bentzen K, Scheibel E, Dalsgård Nielsen J, Dickmeiss E. Scand J Haematol; 1985 Oct; 35(4):379-85. PubMed ID: 3001927 [Abstract] [Full Text] [Related]
3. [Immunological status of hemophiliacs: study of blood T-lymphocyte populations, serum immunoglobulins, and the prevalence of anti-LAV antibodies]. Aymard JP, Janot C, Briquel ME, André E, Schooneman F, Vigneron C, Legras B, Alexandre P, Streiff F. Pathol Biol (Paris); 1985 Dec; 33(10):951-6. PubMed ID: 3005949 [Abstract] [Full Text] [Related]
6. Abnormalities of circulating lymphocyte subsets in haemophiliacs in an AIDS-free population. Carr R, Veitch SE, Edmond E, Peutherer JF, Prescott RJ, Steel CM, Ludlam CA. Lancet; 1984 Jun 30; 1(8392):1431-4. PubMed ID: 6145879 [Abstract] [Full Text] [Related]
8. HTLV III antibodies and immunological alterations in hemophilia patients. Seifried E, Pindur G, Stötter H, Porzsolt F, Rasche H, Erfle V, Hehlmann R, Heimpel H. Klin Wochenschr; 1986 Feb 03; 64(3):115-24. PubMed ID: 3005759 [Abstract] [Full Text] [Related]
9. Differential prevalence of antibody to AIDS-associated retrovirus in haemophiliacs treated with Factor VIII concentrate versus cryoprecipitate: recovery of infectious virus. Koerper MA, Kaminsky LS, Levy JA. Lancet; 1985 Feb 02; 1(8423):275. PubMed ID: 2857339 [No Abstract] [Full Text] [Related]
13. Abnormalities of in vitro immunoglobulin production in apparently healthy haemophiliacs: relationship with alterations of T cell subsets and with HTLV-III seropositivity. Biagiotti R, Giudizi MG, Almerigogna F, Mazzetti M, Alessi A, Del Prete GF, Rafanelli D, Fiorilli M, Morfini M, Romagnani S. Clin Exp Immunol; 1986 Feb 02; 63(2):354-8. PubMed ID: 3009063 [Abstract] [Full Text] [Related]
14. Immunologic abnormalities in patients with hemophilia A. Weintrub PS, Koerper MA, Addiego JE, Drew WL, Lennette ET, Miner R, Cowan MJ, Ammann AJ. J Pediatr; 1983 Nov 02; 103(5):692-5. PubMed ID: 6415259 [Abstract] [Full Text] [Related]
15. T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates. Lechner K, Niessner H, Bettelheim P, Deutsch E, Fasching I, Fuhrmann M, Hinterberger W, Korninger C, Neumann E, Liszka K. Thromb Haemost; 1983 Aug 30; 50(2):552-6. PubMed ID: 6314582 [Abstract] [Full Text] [Related]
16. Immunologic studies in asymptomatic hemophilia patients. Relationship to acquired immune deficiency syndrome (AIDS). Landay A, Poon MC, Abo T, Stagno S, Lurie A, Cooper MD. J Clin Invest; 1983 May 30; 71(5):1500-4. PubMed ID: 6222070 [Abstract] [Full Text] [Related]
19. HIV antibody status and immunological abnormalities in Polish haemophiliacs. Lopaciuk S, Kacperska E, Gloskowska-Moraczewska Z, Maslanka K, Uhrynowska M, Kraj M, Seyfried H. Thromb Haemost; 1987 Feb 03; 57(1):41-3. PubMed ID: 3495899 [Abstract] [Full Text] [Related]
20. Abnormal T-cell subsets and mitogen responses in hemophiliacs exposed to factor concentrate. Unzeitig JC, Church JA, Gomperts ED, Nye CA, Pasquale S, Richards W. Am J Dis Child; 1984 Jul 03; 138(7):645-8. PubMed ID: 6233901 [Abstract] [Full Text] [Related] Page: [Next] [New Search]